Molecular docking and dynamics simulation revealed the anti-breast cancer potential of andaliman (Zanthoxylum acanthopodium DC.) essential oil by targeting cyclin-dependent kinase 1 protein
References
- J.M. Enserink, P. Chymkowitch, Cell cycle-dependent transcription: the cyclin dependent kinase Cdk1 is a direct regulator of basal transcription machineries, International Journal of Molecular Sciences 23 (2022) 1293. Doi: 10.3390/ijms23031293.
- I. Neganova, K. Tilgner, A. Buskin, I. Paraskevopoulou, S.P. Atkinson, D. Peberdy, J.F. Passos, I. Lako, CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells, Cell Death & Disease 5 (2014) e1508. Doi: 10.1038/cddis.2014.464.
- G. Massacci, L. Perfetto, F. Sacco, The cyclin-dependent kinase 1: more than a cell cycle regulator, British Journal of Cancer 129 (2023) 1707–1716. Doi: 10.1038/s41416-023-02468-8.
- Q. Wang, A.M. Bode, T. Zhang, Targeting CDK1 in cancer: mechanisms and implications, NPJ Precision Oncology 7 (2023) 58. Doi: 10.1038/s41698-023-00407-7.
- R. Prevo, G. Pirovano, R. Puliyadi, K.J. Herbert, G. Rodriguez-Berriguete, A. O’Docherty, W. Greaves, W.G. McKenna, G.S. Higgins, CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner, Cell Cycle 17 (2018) 1513–1523. Doi: 10.1080/15384101.2018.1491236.
- J. Kang, C.M. Sergio, R.L. Sutherland, E.A. Musgrove, Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells, BMC Cancer 14 (2014) 32. Doi: 10.1186/1471-2407-14-32.
- Q. Xia, Y. Cai, R. Peng, G. Wu, Y. Shi, W. Jiang, The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition, International Journal of Oncology 44 (2014) 735–744. Doi: 10.3892/ijo.2013.2240.
- U. Mehraj, S. Sofi, B. Alshehri, M.A. Mir, Expression pattern and prognostic significance of CDKs in breast cancer: an integrated bioinformatic study, Cancer Biomarkers 34 (2022) 505–519. Doi: 10.3233/CBM-210186.
- V. Teotia, P. Jha, M. Chopra, Discovery of potential inhibitors of CDK1 by integrating pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation studies, and evaluation of their inhibitory activity, ACS Omega 9 (2024) 39873–39892. Doi: 10.1021/acsomega.4c05414.
- A.P. Duarte, Â. Luís, E. Gallardo, Natural products: therapeutic properties and beyond II, Molecules 27 (2022) 6140. Doi:10.3390/molecules27196140.
- K. Dzobo, The role of natural products as sources of therapeutic agents for innovative drug discovery, Comprehensive Pharmacology (2022) 408–422. Doi: 10.1016/B978-0-12-820472-6.00041-4.
- Adrian, R.A. Syahputra, N.A. Juwita, R. Astyka, M.F. Lubis, Andaliman (Zanthoxylum acanthopodium DC.) a herbal medicine from North Sumatera, Indonesia: phytochemical and pharmacological review, Heliyon 9 (2023) e16159. Doi: 10.1016/j.heliyon.2023.e16159.
- A.W. Septama, E.P. Rahmi, A.N. Tasfiyati, N.A. Khairunnisa, H.R. Nasution, N. Nirmal, S.D.S. Banjarnahor, Nurhadi, D. Priyatmojo, Chemical profiles and antibacterial actions of Zanthoxylum acanthopodium DC. essential oil growing in Indonesia, Fitoterapia 180 (2025) 106300. Doi: 10.1016/j.fitote.2024.106300.
- A. Daina, O. Michielin, V. Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Scientific Reports 7 (2017) 42717. Doi: 10.1038/srep42717.
- P. Banerjee, E. Kemmler, M. Dunkel, R. Preissner, ProTox 3.0: a webserver for the prediction of toxicity of chemicals, Nucleic Acids Research 52 (2024) W513–W520. Doi: 10.1093/nar/gkae303.
- D.A. Filimonov, A.A. Lagunin, T.A. Gloriozova, A.V. Rudik, D.S. Druzhilovskii, P.V. Pogodin, V.V. Poroikov, Prediction of the biological activity spectra of organic compounds using the PASS online web resource, Chemistry of Heterocyclic Compounds 50 (2014) 444–457. Doi: 10.1007/s10593-014-1496-1.
- A. Daina, O. Michielin, V. Zoete, SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Research 47 (2019) W357–W364. Doi: 10.1093/nar/gkz382.
- D.S. Chandrashekar, S.K. Karthikeyan, P.K. Korla, H. Patel, A.R. Shovon, M. Athar, G.J. Netto, Z.S. Qin, S. Kumar, U. Manne, C.J. Creighton, S. Varambally, UALCAN: an update to the integrated cancer data analysis platform, Neoplasia 25 (2022) 18–27. Doi: 10.1016/j.neo.2022.01.001.
- H. Heberle, G.V. Meirelles, F.R. da Silva, G.P. Telles, R. Minghim, InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams, BMC Bioinformatics 16 (2015) 169. Doi: 10.1186/s12859-015-0611-3.
- D. Szklarczyk, R. Kirsch, M. Koutrouli, K. Nastou, F. Mehryary, R. Hachilif, A.L. Gable, T. Fang, N.T. Doncheva, S. Pyysalo, P. Bork, L.J. Jensen, C. von Mering, The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest, Nucleic Acids Research 51 (2023) D638–D646. Doi: 10.1093/nar/gkac1000.
- J. Gao, B.A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross, O. Sumer, Y. Sun, A. Jacobsen, R. Sinha, E. Larsson, E. Cerami, C. Sander, N. Schultz, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Science Signaling 6 (2013) pl1. Doi:10.1126/scisignal.2004088.
- Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Research 45 (2017) W98–W102. Doi: 10.1093/nar/gkx247.
- M. Uhlén, L. Fagerberg, B.M. Hallström, C. Lindskog, P. Oksvold, A. Mardinoglu, Å. Sivertsson, C. Kampf, E. Sjöstedt, A. Asplund, I. Olsson, K. Edlund, E. Lundberg, S. Navani, C.A. Szigyarto, J. Odeberg, D. Djureinovic, J.O. Takanen, S. Hober, T. Alm, P.H. Edqvist, H. Berling, H. Tegel, J. Mulder, J. Rockberg, P. Nilsson, J.M. Schwenk, M. Hamsten, K. von Feilitzen, M. Forsberg, L. Persson, F. Johansson, M. Zwahlen, G. von Heijne, J. Nielsen, F. Pontén, Tissue-based map of the human proteome, Science 347 (2015) 1260419. Doi: 10.1126/science.1260419.
- T. Li, J. Fan, B. Wang, N. Traugh, Q. Chen, J.S. Liu, B. Li, X.S. Liu, TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells, Cancer Research 77 (2017) e108–e110. Doi: 10.1158/0008-5472.CAN-17-0307.
- H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne, The Protein Data Bank, Nucleic Acids Research 28 (2000) 235–242. Doi: 10.1093/nar/28.1.235.
- D.J. Wood, S. Korolchuk, N.J. Tatum, L.Z. Wang, J.A. Endicott, M.E.M. Noble, M.P. Martin, Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition, Cell Chemical Biology 26 (2019) 121–130.e5. Doi:10.1016/j.chembiol.2018.10.015.
- M. Wiederstein, M.J. Sippl, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic Acids Research 35 (2007) W407–W410. Doi:10.1093/nar/gkm290.
- S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, P.A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, E.E. Bolton, PubChem 2023 update, Nucleic Acids Research 51 (2023) D1373–D1380. Doi: 10.1093/nar/gkac956.
- S. Dallakyan, A.J. Olson, Small-molecule library screening by docking with PyRx, Methods in Molecular Biology 1263 (2015) 243–250. Doi: 10.1007/978-1-4939-2269-7_19.
- K. Ozvoldik, T. Stockner, E. Krieger, YASARA model—interactive molecular modeling from two dimensions to virtual realities, Journal of Chemical Information and Modeling 63 (2023) 6177–6182. Doi:10.1021/acs.jcim.3c01136.
- Y. Wang, X. Chen, Identification of potential MMP-8 inhibitors through virtual screening of natural product databases, In Silico Pharmacology 13 (2025) 11. Doi: 10.1007/s40203-024-00299-w.
- F. Qi, Q. Yan, Z. Zheng, J. Liu, Y. Chen, G. Zhang, Geraniol and geranyl acetate induce potent anticancer effects in colon cancer Colo-205 cells by inducing apoptosis, DNA damage and cell cycle arrest, Journal of BUON 23 (2018) 346–352.
- D. Moris, M. Kontos, E. Spartalis, I.S. Fentiman, The role of NSAIDs in breast cancer prevention and relapse: current evidence and future perspectives, Breast Care 11 (2016) 339–344. Doi: 10.1159/000452315.
- Z.X. Zhang, W.J. Jin, S. Yang, C.L. Ji, BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2, American Journal of Cancer Research 6 (2016) 1040–1052.
- M.F. Mercogliano, S. Bruni, P.V. Elizalde, R. Schillaci, Tumor necrosis factor α blockade: an opportunity to tackle breast cancer, Frontiers in Oncology 10 (2020) 584. Doi:10.3389/fonc.2020.00584.
- L. Yuan, Y. Cai, L. Zhang, S. Liu, P. Li, X. Li, Promoting apoptosis, a promising way to treat breast cancer with natural products: a comprehensive review, Frontiers in Pharmacology 12 (2022) 801662. Doi:10.3389/fphar.2021.801662.
- M. Schwermer, S. Lee, J. Köster, T. Van Maerken, H. Stephan, A. Eggert, K. Morik, J.H. Schulte, A. Schramm, Sensitivity to CDK1 inhibition is modulated by p53 status in preclinical models of embryonal tumors, Oncotarget 6 (2015) 15425–15435. Doi: 10.18632/oncotarget.3908.
- R. Wijnen, C. Pecoraro, D. Carbone, H. Fiuji, A. Avan, G.J. Peters, E. Giovannetti, P. Diana, Cyclin dependent kinase-1 (CDK-1) inhibition as a novel therapeutic strategy against pancreatic ductal adenocarcinoma (PDAC), Cancers 13 (2021) 4389. Doi: 10.3390/cancers13174389.
- H. Raskov, A. Orhan, S. Gaggar, I. Gögenur, Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy, Oncogenesis 11 (2022) 22. Doi: 10.1038/s41389-022-00398-3.
- N. Tumino, P.F. Fiore, A. Pelosi, L. Moretta, P. Vacca, Myeloid derived suppressor cells in tumor microenvironment: interaction with innate lymphoid cells, Seminars in Immunology 61–64 (2022) 101668. Doi:10.1016/j.smim.2022.101668.
- Y. Yang, Q. Liu, X. Guo, Q. Yuan, S. Nian, P. Kang, Z. Xu, L. Li, Y. Ye, Systematic pan-cancer analysis identifies CDK1 as an immunological and prognostic biomarker, Journal of Oncology (2022) 1–24. Doi: 10.1155/2022/8115474.
- P.C. Agu, C.A. Afiukwa, O.U. Orji, E.M. Ezeh, I.H. Ofoke, C.O. Ogbu, E.I. Ugwuja, P.M. Aja, Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management, Scientific Reports 13 (2023) 13398. Doi: 10.1038/s41598-023-40160-2.
- T. Chen, X. Shu, H. Zhou, F.A. Beckford, M. Misir, Algorithm selection for protein-ligand docking: strategies and analysis on ACE, Scientific Reports 13 (2023) 8219. Doi: 10.1038/s41598-023-35132-5.
- S.R. Durell, A. Ben-Naim, Temperature dependence of hydrophobic and hydrophilic forces and interactions, The Journal of Physical Chemistry B 125 (2021) 13137–13146. Doi: 10.1021/acs.jpcb.1c07802.
- L. Chen, B.Q. Li, M.Y. Zheng, J. Zhang, K.Y. Feng, Y.D. Cai, Prediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways, BioMed Research International (2013) 723780. Doi: 10.1155/2013/723780.
- N. Rana, P. Solanki, R. Mehra, A. Manhas, Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: insights from structure-based drug design and biomolecular simulations, Chemical Physics Impact 10 (2025) 1–20. Doi: 10.1016/j.chphi.2024.100809.
- A. Hidayatullah, W.E. Putra, S. Sustiprijatno, D. Widiastuti, W.O. Salma, M.F. Heikal, Molecular docking and molecular dynamics simulation-based identification of natural inhibitors against druggable human papilloma virus type 16 target, Trends in Sciences 20 (2023) 4891. Doi: 10.48048/tis.2023.4891.
DOI: https://doi.org/10.2478/auoc-2026-0008 | Journal eISSN: 2286-038X (formerly 1223-7221) | Journal ISSN: 1583-2430 (formerly 1223-7221)
Language: English
Page range: 67 - 79
Submitted on: Mar 14, 2026
Accepted on: Sep 22, 2026
Published online: Oct 6, 2026
Published in print: Jul 1, 2026
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Wira Eka Putra, Diana Widiastuti, Sustiprijatno Sustiprijatno, Hary Isnanto, Arief Hidayatullah, Muhammad Fikri Heikal, Dewi Ratih Tirto Sari, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.